Login to Your Account



New Partner Wanted

Cytokinetics Is All Muscle: Ends Cancer Deal with GSK

By Trista Morrison


Friday, December 11, 2009
A year after GlaxoSmithKline plc backed away from two cancer drugs covered under its collaboration with Cytokinetics Inc., the big pharma handed back rights to the third and final compound as well. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription